BeyondSpring (BYSI) Non Operating Interest Expenses (2019 - 2021)
BeyondSpring's (BYSI) quarterly Non Operating Interest Expenses came in at $21000.0 in Q4 2021, down 4.55% year-over-year from $22000.0 in Q4 2020, and up 5.0% quarter-over-quarter from $20000.0 in Q3 2021.
Analysis
BeyondSpring (BYSI) Non Operating Interest Expenses (2019 - 2021) Analysis & Trends
BeyondSpring has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting $21000.0 for Q4 2021.
- In Q4 2021, Non Operating Interest Expenses fell 4.55% year-over-year to $21000.0; the TTM figure through Dec 2021 stood at $87000.0 (up 2.35% YoY), while the FY2022 annual figure was $17000.0, down 80.46% from the prior year.
- Non Operating Interest Expenses came in at $21000.0 for Q4 2021 at BeyondSpring, up from $20000.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $103000.0 in Q2 2019 to a low of $20000.0 in Q4 2019.
- Average Non Operating Interest Expenses over 3 years is $31500.0, with a median of $21500.0 recorded in 2020.
- Year-over-year, Non Operating Interest Expenses slumped 79.61% in 2020 and climbed 14.29% in 2021.
- Over 3 years, Non Operating Interest Expenses stood at $20000.0 in 2019, then gained by 10.0% to $22000.0 in 2020, then fell by 4.55% to $21000.0 in 2021.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $21000.0 in Q4 2021, $20000.0 in Q3 2021, and $22000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | - |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | -333.60 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 23.78 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 582,000.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 2.90 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 22,000.00 |
| Mar 31, 2021 | 24,000.00 |
| Dec 31, 2020 | 22,000.00 |
| Sep 30, 2020 | 21,000.00 |
| Jun 30, 2020 | 21,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Dec 31, 2019 | 20,000.00 |
| Sep 30, 2019 | 46,000.00 |
| Jun 30, 2019 | 103,000.00 |
| Mar 31, 2019 | 37,000.00 |